July 13, 2015

The average lost time worker's compensation claim for workers using opioid painkillers can total as much as $117,000 — 900% higher than the cost for workers who do not take opioid painkillers, the National Safety Council says. 

July 13, 2015

Shopper’s Drug Mart and Loblaw pharmacy are partnering with the Partnership for a Drug Free Canada for the National Medicine Take-Back Campaign. 

July 9, 2015

Congress pressures CMS to create regulatory framework around generic drug price transparency. 

July 9, 2015

 Mylan announced Thursday that it had launched its generic version of Valeant’s Targretin (bexarotene) 75-mg capsules.

July 9, 2015

PillPack's Medication Reminders mobile app uses geo-tracking sensors to create custom reminders based on location, activity or time.

July 9, 2015

Sandoz has launched its generic version of Angiomax (bivalirudin), an anticoagulant injection. 

July 7, 2015

Ateb announced Tuesday that it had appointed Mike Cantrell as VP for pharmacy network development and Mike Roberts as the director of analytics and pharmacy programs

July 7, 2015

Teva announced Tuesday that it had introduced its generic version of Axert (almotriptan malate) tablets. 

July 6, 2015

The Harvard Drug Group enhances Cardinal Health's generic distribution business, expands OTC portfolio. 

July 1, 2015

The new purple logo is meant to express dynamism, creativity and empathy — three values at the heart of its mission to patients, Dr. Reddy's noted in a statement.

July 1, 2015

New exchange plan enrollees spent less on medications in the first quarter of 2015 compared with the same time a year ago, according to the third edition of the Express Scripts Exchange Pulse report released on Wednesday.

July 1, 2015

An analysis of five pharmacy case studies conducted for the National Community Pharmacists Association has found that medication synchronization brings positive results to community pharmacy.

July 1, 2015

Teva Pharmaceuticals announced the U.S.-wide availability of generic Aggrenox (aspirin and extended-release dipyridamole) capsules, which contain that can reduce the risk of stroke, on Wednesday.

June 30, 2015

The GPhA's Biosimilars Council cautions FDA against adopting distinguishable names for biosimilars and biologics. 

June 30, 2015

The Food and Drug Administration on Tuesday issued guidance indicating that the agency would give pharmacies  an additional four months to comply with product tracing requirements scheduled to take effect July 1, 2015.

June 30, 2015

The International Generic Pharmaceutical Alliance has issued a statement calling on parties negotiating the Trans-Pacific Partnership to make access to affordable medication a priority.

June 26, 2015

Kevin Kettler, SVP marketing, U.S. Pharmaceutical at McKesson, took Drug Store News on a guided tour of the McKesson ideaShare show floor following the Opening General Session yesterday. The five stations included on the tour are designed to increase access to patients, help bring those patients into the store and maximize these patients by offering new services to bring in new revenue.

June 26, 2015

Gov. Tom Wolf signed into law on Friday House Bill 182, which allows pharmacists to administer the flu vaccine to patients 9 years of age and older, with parental consent.

June 24, 2015

Aurobindo Pharma Limited has announced that it has received final approval from the U.S. Food and Drug Administration for entacapone tablets USP, 200 mg, the generic equivalent to Comtan Tablets 200 mg.

June 24, 2015

Pharmacy organizations have written a joint letter to the Food and Drug Administration asking officials to delay enforcement of a July 1 electronic product-tracing deadline for prescription drug dispensers.

June 23, 2015

The Food and Drug Administration is concerned that too great a deviance from a reference drug appearance could affect compliance. 

June 23, 2015

Sandoz has launched Glatopa, the first U.S. generic of Teva’s Copaxone (glatiramer acetate injection, 20-mg/ml ), a once-daily treatment for multiple sclerosis. 

June 23, 2015

Teva announced Monday that it had introduced its generic version of Focalin XR (dexmethylphenidate hydrochloride) extended-release capsules in a new 20-mg dosage strength. 

June 19, 2015

The move gives Teva standing in Dutch court, should they decide to pursue action against Mylan.